SP-CHE-008-3
HA-DOTATATE - Radioligand, precursor for radiolabeled HA-DOTATATE and ligand for somatostatin receptors. Can be bound to radionuclides for development of cancer treatment and diagnosis. For research use only!
We provide the peptide in a range of aliquot sizes, ensuring flexibility for diverse research applications. For any special requirements, please contact our customer support: peptide@jpt.com
One focus of JPT’s product development is oncology. Therefore, we offer a huge variety of TAA peptide, peptide pools and microarrays, as well as <DOTA peptides and radio sensitizers. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.Have a look at our Peptide Tools to Study Cancer.
Benefits of JPT's Single Catalogue Peptides
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
References:
Read References with Specialty Peptides
| Properties | Values |
|---|---|
| Application: | Nuclear medicine |
| Category: | Chelate Peptides (DOTA) |
| Condition / Topic: | Cancer |
| Layout: | Freeze-dried in plastic vial |
| Organism: | Artificial |
| Protein Name: | Other |
| Purity: | >95% (HPLC-MS) |
| Quantification: | No |
| Information | Values |
|---|---|
| Sequence: | DOTA-DPhe-C-Tyr(3-I)-DTrp-KTCT-OH (Tyr(3-I) = 3-iodo-L-tyrosine |
Check our list of products, click and go.
Get a quote
-CAS909024-55-1.jpg "DOTA-cyclo(RGDfK) - CAS 909024-55-1")
